The 2023 Precision Oncology Summit was held in San Francisco on October 7 th and 8 th , focusing on actionable strategies addressing personalized treatment to improve patient outcomes. This manuscript summarizes the discussion and key learning points from “The Revolution in Germline DNA Testing” session.
No takes yet. Share an insight, caveat, or question.
Abuali et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: